ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Methotrexate Shortage: Why It’s Happening & Potential Solutions

Michele B. Kaufman, PharmD, BCGP  |  May 31, 2023

In recent months, many rheumatologists and rheumatology professionals have noted issues related to obtaining supplies of injectable and oral methotrexate for their patients with rheumatoid arthritis (RA). A conventional synthetic disease-modifying anti-rheumatic drug (csDMARD), methotrexate is available as both oral tablets and as a subcutaneous injection for the treatment of RA and other autoimmune diseases.1…

Filed under:Drug Updates Tagged with:Drug shortagedrug treatmentMethotrexatepatient careRheumatoid Arthritis (RA)

Adobe Stock / ART STOCK CREATIVE

Large Language Models in Medicine: The potential to reduce workloads, leverage the EMR for better communication & more

Jacqueline Jansz, MD, & Peter T. Sadelski, JD  |  May 17, 2023

Large language models are a type of AI that allows users to generate new content, drawing from a huge dataset to learn how to mimic “natural language” with many possible beneficial applications for this technology in medicine.

Filed under:AppsHome SliderPractice SupportTechnology Tagged with:AIartificial intelligencelarge language model

Rheum After 5: Dr. Brittany Bettendorf, Figure Skater

Carol Patton  |  May 11, 2023

When she was 2 years old, Brittany A. Bettendorf, MD, MFA, a rheumatologist at the University of Iowa (UI) Hospitals and Clinics, Iowa City, was introduced to figure skating by her mother, a national roller-skating champion and amateur figure skater. “The first time I stepped on the ice, I loved it,” she says. Dr. Bettendorf…

Filed under:ProfilesRheum After 5 Tagged with:Dr. Brittany Bettendorf

New Study Probes Hydroxychloroquine Adherence During Pregnancy

Antonia Chan & Julia F. Simard, ScD  |  May 11, 2023

Hydroxychloroquine (HCQ) is nearly universally recommended for pregnant patients with systemic lupus erythematosus (SLE) to reduce lupus disease activity and adverse outcomes in pregnancy.1-3 Yet despite strong evidence supporting its benefits, HCQ appears underutilized, with several studies suggesting fewer than half of all women with lupus take this medication during pregnancy.4 How accurately these results…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:adherenceHydroxychloroquine (HCQ)pregnancy

In the Wake of Dobbs v. Jackson Women’s Health Organization

Mary Beth Nierengarten  |  May 10, 2023

Since the Supreme Court ruling in June 2022 overturning 50 years of precedent protecting abortion as a constitutional right (Dobbs v. Jackson Women’s Health Organization), states are enacting and implementing new laws to regulate abortion, and medical organizations and healthcare providers are assuming the large task of understanding what the new laws mean for their…

Filed under:EthicsLegal UpdatesProfessional Topics Tagged with:abortionDobbs v. Jackson Women's Health Organization

What Is the Essence of Being a Rheumatologist?

Carlos Antonio Moura, MD, with Carlos Geraldo Moura, PhD  |  May 9, 2023

I am often asked by medical students, resident physicians and—especially—patients, what is rheumatology? When students ask me why I chose to be a rheumatologist, I answer that I have never been in love with pathologies, such as rheumatoid arthritis, spondyloarthritis, gout, osteoporosis, systemic lupus erythematosus or vasculitis. In fact, I chose rheumatology because I love…

Filed under:OpinionProfessional TopicsSpeak Out Rheum Tagged with:Speak Out Rheumatology

Letter to the Editor: A Workforce Shortage Solution

David Engelbrecht, MD  |  May 9, 2023

The issue of the rheumatology workforce shortage is certainly vexing. Not only does it leave large segments of the population without adequate care for patients with serious rheumatic diseases, but it also increases the burden on the few rheumatologists who serve populous, underserved regions of the country. Solutions suggested in The Rheumatologist (“ACR Workforce Solutions…

Filed under:OpinionPractice SupportProfessional TopicsSpeak Out Rheum Tagged with:letter to the editorLettersretirementWorkforce

2 AC&R Study Summaries: Racial Disparities in Lupus Trials & Post-Discharge Follow-Up in Lupus

Arthritis Care & Research  |  May 9, 2023

Racial Disparities in Lupus Clinical Trial Participation By Saira Z. Sheikh, MD Why was this study done? Lupus disproportionately affects Black and Latino populations, particularly women in childbearing years. Clinical trials of patients with lupus can advance the development of therapeutics and access to better treatments, as well as improve health outcomes for patients. However,…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:dischargeDisparitiesFollow-UpLupusReading Rheumsystemic lupus erythematosus (SLE)

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD  |  May 9, 2023

Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated…

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportGranulomatosisgranulomatosis with polyangiitismigratory polyarthritis

Complain Constructively: It’s Called Advocacy

Belinda Birnbaum, MD  |  May 8, 2023

It’s easy for rheumatologists and rheumatology professionals to feel frustrated by burdensome administrative tasks, complicated insurance policies and other healthcare hurdles. Advocacy offers a way to channel those complaints into constructive action, says Belinda Birnbaum, MD.

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyBelinda BirnbaumGovernment Affairs Committee (GAC)

  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 328
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences